05 Nov PCOS – Polycystic Ovary Syndrome: Should it be Renamed?
MedicalResearch.com Interview with:
Professor Helena Teede MBBS, PhD, FRACP
Director Monash Centre for Health Research and Implementation — MCHRI,
And Head Womens Public Health Research, School Public Health and Preventive Medicine Monash University, in partnership with Monash Health
Head Diabetes and Vascular Medicine, Monash Health
President Elect- Endocrine Society of Australia
NHMRC Practitioner Fellow
43-51 Kanooka Grove, Clayton, Victoria 3168 Australia
MedicalResearch.com: What are the main findings of the study?
Dr. Teede: PCOS is a historical but histopathologically inaccurate name for a common condition that is a source of confusion for women and primary health care providers.
MedicalResearch.com: Were any of the findings unexpected?
Dr. Teede: The unexpected findings were that many women and primary care providers do not have a good understanding of the features of PCOS outside of reproductive features. These include the metabolic (diabetes risk) and psychological factors in PCOS.
MedicalResearch.com: What should clinicians and patients take away from your report?
Dr. Teede: An awareness that the condition is inappropriately named and that it is caused by hormonal changes which underpin PCOS and cause metabolic and reproductive features including secondary functional ovary changes.
MedicalResearch.com: What recommendations do you have for future research as a result of this study?
Dr. Teede: Further research needs to explore other suitable names for the syndrome and needs to assess the results of new guidelines and education programs to improve consumer and clinician understanding of PCOS.